{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:39:50Z","timestamp":1792571990219,"version":"4.5.0"},"reference-count":110,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universidade Federal Do Delta Do Parna\u00edba","id":[{"id":"https:\/\/ror.org\/014n7xm98","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05723-7","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:41:08Z","timestamp":1789119668000},"page":"5397-5418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nutrient deprivation enhances the cytotoxic effects of a sulfonamide-chalcone hybrid in PC-3 prostate cancer cells"],"prefix":"10.1007","volume":"481","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1756-6823","authenticated-orcid":false,"given":"Gisele Santos","family":"de Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1492-3995","authenticated-orcid":false,"given":"Rodrigo El\u00edsio","family":"de S\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0196-6264","authenticated-orcid":false,"given":"St\u00e9phanie Aguiar","family":"de Negreiros Matos Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1637-5934","authenticated-orcid":false,"given":"Fabr\u00edcio","family":"dos Santos Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0586-0774","authenticated-orcid":false,"given":"Caridad Noda","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6444-4098","authenticated-orcid":false,"given":"Mirian Rita Carrilho","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6305-539X","authenticated-orcid":false,"given":"Anali","family":"Del Milagro Bernabe Garnique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5884-1975","authenticated-orcid":false,"given":"Bruna Oliveira","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5498-7539","authenticated-orcid":false,"given":"Keli","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2937-8109","authenticated-orcid":false,"given":"Jo\u00e3o Agostinho","family":"Machado Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1861-5153","authenticated-orcid":false,"given":"Let\u00edcia Veras","family":"Costa Lotufo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2493-6159","authenticated-orcid":false,"given":"Jos\u00e9 Delano Barreto","family":"Marinho Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7182-7097","authenticated-orcid":false,"given":"Ana J\u00e9rsia","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"5723_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202500847","author":"E L\u00f3pez-L\u00f3pez","year":"2026","unstructured":"L\u00f3pez-L\u00f3pez E, Espinoza\u2010Casta\u00f1eda JI, Martinez\u2010Mayorga K, Medina\u2010Franco JL (2026) Structure\u2013property associations: breaking paradigms for linking chemical structures and biological properties in drug discovery. ChemMedChem. https:\/\/doi.org\/10.1002\/cmdc.202500847","journal-title":"ChemMedChem"},{"key":"5723_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103730","volume":"28","author":"K Wu","year":"2023","unstructured":"Wu K, Karapetyan E, Schloss J et al (2023) Advancements in small molecule drug design: a structural perspective. Drug Discov Today 28:103730. https:\/\/doi.org\/10.1016\/j.drudis.2023.103730","journal-title":"Drug Discov Today"},{"key":"5723_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041104","volume":"19","author":"A Pawe\u0142czyk","year":"2018","unstructured":"Pawe\u0142czyk A, Sowa-Kasprzak K, Olender D, Zaprutko L (2018) Molecular consortia\u2014various structural and synthetic concepts for more effective therapeutics synthesis. Int J Mol Sci 19:1104. https:\/\/doi.org\/10.3390\/ijms19041104","journal-title":"Int J Mol Sci"},{"key":"5723_CR4","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.2174\/1568026619666190619115735","volume":"19","author":"V Ivasiv","year":"2019","unstructured":"Ivasiv V, Albertini C, Gon\u00e7alves AE et al (2019) Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases. Curr Top Med Chem 19:1694\u20131711. https:\/\/doi.org\/10.2174\/1568026619666190619115735","journal-title":"Curr Top Med Chem"},{"key":"5723_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ejmech.2016.08.042","volume":"124","author":"SP Bahekar","year":"2016","unstructured":"Bahekar SP, Hande SV, Agrawal NR et al (2016) Sulfonamide chalcones: Synthesis and in vitro exploration for therapeutic potential against Brugia malayi. Eur J Med Chem 124:262\u2013269. https:\/\/doi.org\/10.1016\/j.ejmech.2016.08.042","journal-title":"Eur J Med Chem"},{"key":"5723_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ejmech.2019.05.013","volume":"176","author":"LF Casta\u00f1o","year":"2019","unstructured":"Casta\u00f1o LF, Cuartas V, Bernal A et al (2019) New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity. Eur J Med Chem 176:50\u201360. https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.013","journal-title":"Eur J Med Chem"},{"key":"5723_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105753","volume":"220","author":"V Cao","year":"2023","unstructured":"Cao V, Sukanadi IP, Loeanurit N et al (2023) A sulfonamide chalcone inhibited dengue virus with a potential target at the SAM-binding site of viral methyltransferase. Antivir Res 220:105753. https:\/\/doi.org\/10.1016\/j.antiviral.2023.105753","journal-title":"Antivir Res"},{"key":"5723_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202300440","author":"NS de Oliveira","year":"2024","unstructured":"de Oliveira NS, de Souza LG, de Almeida VM et al (2024) Synthesis and evaluation of hybrid sulfonamide-chalcones with potential antileishmanial activity. Arch Pharm (Weinheim). https:\/\/doi.org\/10.1002\/ardp.202300440","journal-title":"Arch Pharm (Weinheim)"},{"key":"5723_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.109127","volume":"166","author":"JMT Souza","year":"2025","unstructured":"Souza JMT, de Negreiros Matos Silva SA, de S\u00e1 RE et al (2025) ZnO nanoparticles enhance the cytotoxic effects of a chalcone-sulfonamide hybrid by impairing the autophagic flux and upregulating HIF-1\u03b1 expression. Bioorg Chem 166:109127. https:\/\/doi.org\/10.1016\/j.bioorg.2025.109127","journal-title":"Bioorg Chem"},{"key":"5723_CR10","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3109\/00498254.2012.754112","volume":"43","author":"D Maydt","year":"2013","unstructured":"Maydt D, De Spirt S, Muschelknautz C et al (2013) Chemical reactivity and biological activity of chalcones and other \u03b1,\u03b2-unsaturated carbonyl compounds. Xenobiotica 43:711\u2013718. https:\/\/doi.org\/10.3109\/00498254.2012.754112","journal-title":"Xenobiotica"},{"key":"5723_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30122498","volume":"30","author":"F-X Toublet","year":"2025","unstructured":"Toublet F-X, Laurent A, Pouget C (2025) A review of natural and synthetic chalcones as anticancer agents targeting topoisomerase enzymes. Molecules 30:2498. https:\/\/doi.org\/10.3390\/molecules30122498","journal-title":"Molecules"},{"key":"5723_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179623","volume":"25","author":"SM Villa","year":"2024","unstructured":"Villa SM, Heckman J, Bandyopadhyay D (2024) Medicinally privileged natural chalcones: abundance, mechanisms of action, and clinical trials. Int J Mol Sci 25:9623. https:\/\/doi.org\/10.3390\/ijms25179623","journal-title":"Int J Mol Sci"},{"key":"5723_CR13","doi-asserted-by":"publisher","first-page":"818","DOI":"10.2174\/1385272822666180122153839","volume":"22","author":"FA Khan","year":"2018","unstructured":"Khan FA, Mushtaq S, Naz S et al (2018) Sulfonamides as potential bioactive scaffolds. Curr Org Chem 22:818\u2013830. https:\/\/doi.org\/10.2174\/1385272822666180122153839","journal-title":"Curr Org Chem"},{"key":"5723_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/bab.2534","volume":"71","author":"C \u00d6zt\u00fcrk","year":"2024","unstructured":"\u00d6zt\u00fcrk C, Kalay E, Gerni S et al (2024) Sulfonamide derivatives with benzothiazole scaffold: synthesis and carbonic anhydrase I\u2013II inhibition properties. Biotechnol Appl Biochem 71:223\u2013231. https:\/\/doi.org\/10.1002\/bab.2534","journal-title":"Biotechnol Appl Biochem"},{"key":"5723_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138074","volume":"1309","author":"T Iqbal","year":"2024","unstructured":"Iqbal T, Khan S, Rahim F et al (2024) Benzothiazole based sulfonamide scaffolds as active inhibitors of alpha-amylase and alpha-glucosidase; synthesis, structure confirmation, In silico molecular docking and ADME analysis. J Mol Struct 1309:138074. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138074","journal-title":"J Mol Struct"},{"key":"5723_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/antiox14010094","volume":"14","author":"EN Mendoza","year":"2025","unstructured":"Mendoza EN, Ciriolo MR, Ciccarone F (2025) Hypoxia-induced reactive oxygen species: their role in cancer resistance and emerging therapies to overcome it. Antioxidants 14:94. https:\/\/doi.org\/10.3390\/antiox14010094","journal-title":"Antioxidants"},{"key":"5723_CR17","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41416-021-01435-5","volume":"125","author":"F Ahmad","year":"2021","unstructured":"Ahmad F, Cherukuri MK, Choyke PL (2021) Metabolic reprogramming in prostate cancer. Br J Cancer 125:1185\u20131196. https:\/\/doi.org\/10.1038\/s41416-021-01435-5","journal-title":"Br J Cancer"},{"key":"5723_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/biom15060826","volume":"15","author":"Y Wang","year":"2025","unstructured":"Wang Y, Chen Y, Wang J (2025) Role of tumor microenvironment in prostate cancer immunometabolism. Biomolecules 15:826. https:\/\/doi.org\/10.3390\/biom15060826","journal-title":"Biomolecules"},{"key":"5723_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13010065","volume":"13","author":"G Petrella","year":"2022","unstructured":"Petrella G, Corsi F, Ciufolini G et al (2022) Metabolic reprogramming of castration-resistant prostate cancer cells as a response to chemotherapy. Metabolites 13:65. https:\/\/doi.org\/10.3390\/metabo13010065","journal-title":"Metabolites"},{"key":"5723_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/metabo13020183","volume":"13","author":"UR Wanjari","year":"2023","unstructured":"Wanjari UR, Mukherjee AG, Gopalakrishnan AV et al (2023) Role of metabolism and metabolic pathways in prostate cancer. Metabolites 13:183. https:\/\/doi.org\/10.3390\/metabo13020183","journal-title":"Metabolites"},{"key":"5723_CR21","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","volume":"20","author":"G Hoxhaj","year":"2020","unstructured":"Hoxhaj G, Manning BD (2020) The PI3K\u2013AKT network at the interface of oncogenic signalling and cancer metabolism. Nat Rev Cancer 20:74\u201388. https:\/\/doi.org\/10.1038\/s41568-019-0216-7","journal-title":"Nat Rev Cancer"},{"key":"5723_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22041743","volume":"22","author":"NV Popova","year":"2021","unstructured":"Popova NV, J\u00fccker M (2021) The role of mTOR signaling as a therapeutic target in cancer. Int J Mol Sci 22:1743. https:\/\/doi.org\/10.3390\/ijms22041743","journal-title":"Int J Mol Sci"},{"key":"5723_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68668-x","volume":"10","author":"EZ White","year":"2020","unstructured":"White EZ, Pennant NM, Carter JR et al (2020) Serum deprivation initiates adaptation and survival to oxidative stress in prostate cancer cells. Sci Rep 10:12505. https:\/\/doi.org\/10.1038\/s41598-020-68668-x","journal-title":"Sci Rep"},{"key":"5723_CR24","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s12013-024-01581-6","volume":"83","author":"M Shukla","year":"2024","unstructured":"Shukla M, Narayan M (2024) Proteostasis and its role in disease development. Cell Biochem Biophys 83:1725\u20131741. https:\/\/doi.org\/10.1007\/s12013-024-01581-6","journal-title":"Cell Biochem Biophys"},{"key":"5723_CR25","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.R120.002190","volume":"20","author":"AB Ross","year":"2021","unstructured":"Ross AB, Langer JD, Jovanovic M (2021) Proteome turnover in the spotlight: approaches, applications, and perspectives. Mol Cell Proteomics 20:100016. https:\/\/doi.org\/10.1074\/mcp.R120.002190","journal-title":"Mol Cell Proteomics"},{"key":"5723_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10555-025-10250-w","volume":"44","author":"X Yang","year":"2025","unstructured":"Yang X, Cao X, Zhu Q (2025) p62\/SQSTM1 in cancer: phenomena, mechanisms, and regulation in DNA damage repair. Cancer Metastasis Rev 44:33. https:\/\/doi.org\/10.1007\/s10555-025-10250-w","journal-title":"Cancer Metastasis Rev"},{"key":"5723_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/cells14131016","volume":"14","author":"S Xiao","year":"2025","unstructured":"Xiao S, Yu Y, Liao M et al (2025) Post-translational modification of p62: roles and regulations in autophagy. Cells 14:1016. https:\/\/doi.org\/10.3390\/cells14131016","journal-title":"Cells"},{"key":"5723_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3390\/stresses5020026","volume":"5","author":"Z Zayani","year":"2025","unstructured":"Zayani Z, Matinahmadi A, Tavakolpournegari A, Bidooki SH (2025) Exploring stressors: impact on cellular organelles and implications for cellular functions. Stresses 5:26. https:\/\/doi.org\/10.3390\/stresses5020026","journal-title":"Stresses"},{"key":"5723_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13070828","volume":"13","author":"Y Wang","year":"2024","unstructured":"Wang Y, He J, Lian S et al (2024) Targeting metabolic\u2013redox nexus to regulate drug resistance: from mechanism to tumor therapy. Antioxidants (Basel, Switzerland) 13:828. https:\/\/doi.org\/10.3390\/antiox13070828","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"5723_CR30","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.1158\/1538-7445.AM2026-4718","volume":"86","author":"E Nesher","year":"2026","unstructured":"Nesher E, Das SR, Koman I (2026) Abstract 4718: Redox reprogramming protects colon cancer cells from disulfidptosis under glucose deprivation. Cancer Res 86:4718\u20134718. https:\/\/doi.org\/10.1158\/1538-7445.AM2026-4718","journal-title":"Cancer Res"},{"key":"5723_CR31","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.2174\/1871520621666211213092121","volume":"22","author":"AF Moura","year":"2021","unstructured":"Moura AF, de Castro MRC, Naves RF et al (2021) New synthetic sulfonamide chalcone induced cell cycle arrest and cell death in colorectal adenocarcinoma metastatic cells (SW-620). Anticancer Agents Med Chem 22:2340\u20132351. https:\/\/doi.org\/10.2174\/1871520621666211213092121","journal-title":"Anticancer Agents Med Chem"},{"key":"5723_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.111115","volume":"398","author":"G Ara\u00fajo","year":"2024","unstructured":"Ara\u00fajo G, Moura AF, Barros AB et al (2024) Sulfonamide-chalcone hybrid compound suppresses cellular adhesion and migration: experimental and computational insight. Chem Biol Interact 398:111115. https:\/\/doi.org\/10.1016\/j.cbi.2024.111115","journal-title":"Chem Biol Interact"},{"key":"5723_CR33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","volume":"65","author":"T Mosmann","year":"1983","unstructured":"Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55\u201363","journal-title":"J Immunol Methods"},{"key":"5723_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153866","volume":"15","author":"K Lima","year":"2023","unstructured":"Lima K, de Miranda LBL, Del Milagro Bernabe Garnique A et al (2023) The multikinase inhibitor AD80 induces mitotic catastrophe and autophagy in pancreatic cancer cells. Cancers (Basel) 15:3866. https:\/\/doi.org\/10.3390\/cancers15153866","journal-title":"Cancers (Basel)"},{"key":"5723_CR35","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1055\/a-2381-5060","volume":"90","author":"RE de S\u00e1","year":"2024","unstructured":"de S\u00e1 RE, de Ara\u00fajo GS, Machado F et al (2024) Withaphysalin derivatives from Iochroma arborescens induce antiproliferative and antimigratory activities in vitro. Planta Med 90:938\u2013948. https:\/\/doi.org\/10.1055\/a-2381-5060","journal-title":"Planta Med"},{"key":"5723_CR36","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/nprot.2008.75","volume":"3","author":"G Repetto","year":"2008","unstructured":"Repetto G, del Peso A, Zurita JL (2008) Neutral red uptake assay for the estimation of cell viability\/cytotoxicity. Nat Protoc 3:1125\u20131131. https:\/\/doi.org\/10.1038\/nprot.2008.75","journal-title":"Nat Protoc"},{"key":"5723_CR37","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.tiv.2012.02.003","volume":"26","author":"AJ Ara\u00fajo","year":"2012","unstructured":"Ara\u00fajo AJ, de Souza AA, da Silva J\u00fanior EN et al (2012) Growth inhibitory effects of 3\u2032-nitro-3-phenylamino nor-beta-lapachone against HL-60: a redox-dependent mechanism. Toxicol In Vitro 26:585\u2013594. https:\/\/doi.org\/10.1016\/j.tiv.2012.02.003","journal-title":"Toxicol In Vitro"},{"key":"5723_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051370","volume":"15","author":"I Giacomini","year":"2023","unstructured":"Giacomini I, Cortini M, Tinazzi M et al (2023) Contribution of mitochondrial activity to doxorubicin-resistance in osteosarcoma cells. Cancers (Basel) 15:1370. https:\/\/doi.org\/10.3390\/cancers15051370","journal-title":"Cancers (Basel)"},{"key":"5723_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175113","volume":"928","author":"YY Jung","year":"2022","unstructured":"Jung YY, Um J-Y, Chinnathambi A et al (2022) Withanolide modulates the potential crosstalk between apoptosis and autophagy in different colorectal cancer cell lines. Eur J Pharmacol 928:175113. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175113","journal-title":"Eur J Pharmacol"},{"key":"5723_CR40","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1021\/acs.jnatprod.5c01020","volume":"88","author":"I Diccini","year":"2025","unstructured":"Diccini I, Parducci NS, de Almeida BO et al (2025) Cephalochromin effects in triple-negative breast cancer cells: apoptosis induction and modulation of survival pathways. J Nat Prod 88:2851\u20132859. https:\/\/doi.org\/10.1021\/acs.jnatprod.5c01020","journal-title":"J Nat Prod"},{"key":"5723_CR41","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/tx800492x","volume":"22","author":"A B\u00f6hme","year":"2009","unstructured":"B\u00f6hme A, Thaens D, Paschke A, Sch\u00fc\u00fcrmann G (2009) Kinetic glutathione chemoassay to quantify thiol reactivity of organic electrophiles\u2014application to \u03b1,\u03b2-unsaturated ketones, acrylates, and propiolates. Chem Res Toxicol 22:742\u2013750. https:\/\/doi.org\/10.1021\/tx800492x","journal-title":"Chem Res Toxicol"},{"key":"5723_CR42","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5534\/wjmh.230153","volume":"42","author":"CJ Lee","year":"2024","unstructured":"Lee CJ, Yoon H (2024) Metabolic adaptation and cellular stress response as targets for cancer therapy. World J Mens Health 42:62. https:\/\/doi.org\/10.5534\/wjmh.230153","journal-title":"World J Mens Health"},{"key":"5723_CR43","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1097\/CM9.0000000000003844","volume":"138","author":"H Ding","year":"2025","unstructured":"Ding H, Meng Q, Zhou J et al (2025) Revisiting the role of metabolic reprogramming as a contributor to prostate cancer disease progression. Chin Med J (Engl) 138:3381\u20133391. https:\/\/doi.org\/10.1097\/CM9.0000000000003844","journal-title":"Chin Med J (Engl)"},{"key":"5723_CR44","doi-asserted-by":"publisher","first-page":"11750","DOI":"10.1039\/D4CC03530E","volume":"60","author":"FE Hanna","year":"2024","unstructured":"Hanna FE, Hunter CA (2024) Polarisation effects on the H-bond acceptor properties of sulfonamides. Chem Commun 60:11750\u201311753. https:\/\/doi.org\/10.1039\/D4CC03530E","journal-title":"Chem Commun"},{"key":"5723_CR45","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.3390\/molecules22101642","volume":"22","author":"C Supuran","year":"2017","unstructured":"Supuran C (2017) Special Issue: Sulfonamides. Molecules 22:1642. https:\/\/doi.org\/10.3390\/molecules22101642","journal-title":"Molecules"},{"key":"5723_CR46","doi-asserted-by":"publisher","DOI":"10.1021\/jacsau.3c00241","author":"P Purder","year":"2023","unstructured":"Purder P, Meyners C, Sugiarto W et al (2023) Deconstructing protein binding of sulfonamides and sulfonamide analogs. JACS Au. https:\/\/doi.org\/10.1021\/jacsau.3c00241","journal-title":"JACS Au"},{"key":"5723_CR47","doi-asserted-by":"publisher","first-page":"7762","DOI":"10.1021\/acs.chemrev.7b00020","volume":"117","author":"C Zhuang","year":"2017","unstructured":"Zhuang C, Zhang W, Sheng C et al (2017) Chalcone: a privileged structure in medicinal chemistry. Chem Rev 117:7762\u20137810. https:\/\/doi.org\/10.1021\/acs.chemrev.7b00020","journal-title":"Chem Rev"},{"key":"5723_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116099","volume":"25","author":"CMC Andr\u00e9s","year":"2024","unstructured":"Andr\u00e9s CMC, P\u00e9rez de la Lastra JM, Bustamante Munguira E et al (2024) Michael acceptors as anti-cancer compounds: coincidence or causality? Int J Mol Sci 25:6099. https:\/\/doi.org\/10.3390\/ijms25116099","journal-title":"Int J Mol Sci"},{"key":"5723_CR49","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.1021\/jacs.0c02721","volume":"142","author":"C Zambaldo","year":"2020","unstructured":"Zambaldo C, Vinogradova EV, Qi X et al (2020) 2-Sulfonylpyridines as tunable, cysteine-reactive electrophiles. J Am Chem Soc 142:8972\u20138979. https:\/\/doi.org\/10.1021\/jacs.0c02721","journal-title":"J Am Chem Soc"},{"key":"5723_CR50","doi-asserted-by":"publisher","first-page":"32333","DOI":"10.1021\/jacs.4c05711","volume":"146","author":"F Ghorbani","year":"2024","unstructured":"Ghorbani F, You S, Grabovyi GA et al (2024) Scalable thiol reactivity profiling identifies azetidinyl oxadiazoles as cysteine-targeting electrophiles. J Am Chem Soc 146:32333\u201332342. https:\/\/doi.org\/10.1021\/jacs.4c05711","journal-title":"J Am Chem Soc"},{"key":"5723_CR51","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.bbagen.2013.09.003","volume":"1840","author":"SB Wall","year":"2014","unstructured":"Wall SB, Smith MR, Ricart K et al (2014) Detection of electrophile-sensitive proteins. Biochim Biophys Acta - Gen Subj 1840:913\u2013922. https:\/\/doi.org\/10.1016\/j.bbagen.2013.09.003","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"5723_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.997919","author":"J-Y Min","year":"2023","unstructured":"Min J-Y, Chun K-S, Kim D-H (2023) The versatile utility of cysteine as a target for cancer treatment. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.997919","journal-title":"Front Oncol"},{"key":"5723_CR53","doi-asserted-by":"publisher","DOI":"10.4172\/2161-0444.1000291","author":"B Zhou","year":"2015","unstructured":"Zhou B (2015) Diverse Molecular Targets for Chalcones with Varied Bioactivities. Med Chem (Los Angeles). https:\/\/doi.org\/10.4172\/2161-0444.1000291","journal-title":"Med Chem (Los Angeles)"},{"key":"5723_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1033003","author":"S-T Liang","year":"2022","unstructured":"Liang S-T, Chen C, Chen R-X et al (2022) Michael acceptor molecules in natural products and their mechanism of action. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2022.1033003","journal-title":"Front Pharmacol"},{"key":"5723_CR55","doi-asserted-by":"publisher","first-page":"15628","DOI":"10.1039\/D5SC03429A","volume":"16","author":"D Feng","year":"2025","unstructured":"Feng D, Li X, Liu J et al (2025) Selectively triggered: ROS-activated Michael acceptor prodrug strategy to enhance tumor targeting efficacy. Chem Sci 16:15628\u201315637. https:\/\/doi.org\/10.1039\/D5SC03429A","journal-title":"Chem Sci"},{"key":"5723_CR56","doi-asserted-by":"publisher","first-page":"7590","DOI":"10.1021\/jm5006918","volume":"57","author":"C J\u00f6st","year":"2014","unstructured":"J\u00f6st C, Nitsche C, Scholz T et al (2014) Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments. J Med Chem 57:7590\u20137599. https:\/\/doi.org\/10.1021\/jm5006918","journal-title":"J Med Chem"},{"key":"5723_CR57","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1021\/acs.jmedchem.6b00788","volume":"60","author":"PA Jackson","year":"2017","unstructured":"Jackson PA, Widen JC, Harki DA, Brummond KM (2017) Covalent Modifiers: A Chemical Perspective on the Reactivity of \u03b1,\u03b2-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions. J Med Chem 60:839\u2013885. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b00788","journal-title":"J Med Chem"},{"key":"5723_CR58","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s13765-016-0168-5","volume":"59","author":"K Lee","year":"2016","unstructured":"Lee K, Lee DH, Kim J-H et al (2016) The chalcone derivative HymnPro generates reactive oxygen species through depletion of intracellular glutathione. Appl Biol Chem 59:391\u2013396. https:\/\/doi.org\/10.1007\/s13765-016-0168-5","journal-title":"Appl Biol Chem"},{"key":"5723_CR59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s11686-020-00291-2","volume":"66","author":"PS Bhoj","year":"2021","unstructured":"Bhoj PS, Bahekar S, Khatri V et al (2021) Role of glutathione in chalcone derivative induced apoptosis of brugia malayi and its possible therapeutic implication. Acta Parasitol 66:406\u2013415. https:\/\/doi.org\/10.1007\/s11686-020-00291-2","journal-title":"Acta Parasitol"},{"key":"5723_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/cryst12010108","volume":"12","author":"SY Shin","year":"2022","unstructured":"Shin SY, Jung E, Lim Y et al (2022) Synthesis, crystal structure, Hirshfeld surface analysis and docking studies of a novel flavone\u2013chalcone hybrid compound demonstrating anticancer effects by generating ROS through glutathione depletion. Crystals 12:108. https:\/\/doi.org\/10.3390\/cryst12010108","journal-title":"Crystals"},{"key":"5723_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.105055","volume":"114","author":"S Luo","year":"2021","unstructured":"Luo S, Dang X, Wang J et al (2021) Biological evaluation of mitochondria targeting small molecules as potent anticancer drugs. Bioorg Chem 114:105055. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105055","journal-title":"Bioorg Chem"},{"key":"5723_CR62","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s12672-023-00857-2","volume":"15","author":"BN Forgie","year":"2024","unstructured":"Forgie BN, Prakash R, Goyeneche AA, Telleria CM (2024) Vitality, viability, long-term clonogenic survival, cytotoxicity, cytostasis and lethality: what do they mean when testing new investigational oncology drugs? Discov Oncol 15:5. https:\/\/doi.org\/10.1007\/s12672-023-00857-2","journal-title":"Discov Oncol"},{"key":"5723_CR63","doi-asserted-by":"publisher","first-page":"8854","DOI":"10.18632\/oncotarget.12673","volume":"8","author":"A Eastman","year":"2017","unstructured":"Eastman A (2017) Improving anticancer drug development begins with cell culture: misinformation perpetrated by the misuse of cytotoxicity assays. Oncotarget 8:8854\u20138866. https:\/\/doi.org\/10.18632\/oncotarget.12673","journal-title":"Oncotarget"},{"key":"5723_CR64","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s00280-019-03863-w","volume":"84","author":"DM Evans","year":"2019","unstructured":"Evans DM, Fang J, Silvers T et al (2019) Exposure time versus cytotoxicity for anticancer agents. Cancer Chemother Pharmacol 84:359\u2013371. https:\/\/doi.org\/10.1007\/s00280-019-03863-w","journal-title":"Cancer Chemother Pharmacol"},{"key":"5723_CR65","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310667","volume":"24","author":"ML Birsa","year":"2023","unstructured":"Birsa ML, Sarbu LG (2023) Hydroxy chalcones and analogs with chemopreventive properties. Int J Mol Sci 24:10667. https:\/\/doi.org\/10.3390\/ijms241310667","journal-title":"Int J Mol Sci"},{"key":"5723_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.18632\/genesandcancer.237","volume":"15","author":"A Nazmeen","year":"2024","unstructured":"Nazmeen A, Maiti S, Maiti S (2024) Dialyl-sulfide with trans-chalcone prevent breast cancer prohibiting SULT1E1 malregulations and oxidant-stress induced HIF1a-MMPs induction. Genes Cancer 15:41\u201359. https:\/\/doi.org\/10.18632\/genesandcancer.237","journal-title":"Genes Cancer"},{"key":"5723_CR67","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b21-00991","author":"Z Huang","year":"2022","unstructured":"Huang Z, Jin G (2022) Licochalcone B induced apoptosis and autophagy in osteosarcoma tumor cells via the inactivation of PI3K\/AKT\/mTOR pathway. Biol Pharm Bull. https:\/\/doi.org\/10.1248\/bpb.b21-00991","journal-title":"Biol Pharm Bull"},{"key":"5723_CR68","doi-asserted-by":"publisher","first-page":"25265","DOI":"10.1021\/acsomega.2c02181","volume":"7","author":"AA Noser","year":"2022","unstructured":"Noser AA, Shehadi IA, Abdelmonsef AH, Salem MM (2022) Newly synthesized pyrazolinone chalcones as anticancer agents via inhibiting the PI3K\/Akt\/ERK1\/2 signaling pathway. ACS Omega 7:25265\u201325277. https:\/\/doi.org\/10.1021\/acsomega.2c02181","journal-title":"ACS Omega"},{"key":"5723_CR69","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s43440-025-00721-w","volume":"77","author":"S-H Lee","year":"2025","unstructured":"Lee S-H, Lee H, Kwon Y-J et al (2025) Chalcone-9: a novel inhibitor of the JAK-STAT pathway with potent anti-cancer effects in triple-negative breast cancer cells. Pharmacol Rep 77:761\u2013774. https:\/\/doi.org\/10.1007\/s43440-025-00721-w","journal-title":"Pharmacol Rep"},{"key":"5723_CR70","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/nu16040514","volume":"16","author":"X Wang","year":"2024","unstructured":"Wang X, Liang Y, Zhang B et al (2024) 2\u2019-hydroxychalcone induces autophagy and apoptosis in breast cancer cells via the inhibition of the NF-\u03baB signaling pathway: in vitro and in vivo studies. Nutrients 16:514. https:\/\/doi.org\/10.3390\/nu16040514","journal-title":"Nutrients"},{"key":"5723_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/ph16030461","volume":"16","author":"H Gao","year":"2023","unstructured":"Gao H, Li Z, Wang K et al (2023) Design, synthesis, and biological evaluation of sulfonamide methoxypyridine derivatives as novel PI3K\/mTOR dual inhibitors. Pharmaceuticals (Basel) 16:461. https:\/\/doi.org\/10.3390\/ph16030461","journal-title":"Pharmaceuticals (Basel)"},{"key":"5723_CR72","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10517-023-05835-w","volume":"175","author":"AL Khokhlov","year":"2023","unstructured":"Khokhlov AL, Shetnev AA, Korsakov MK et al (2023) Pharmacological properties of sulfonamide derivatives, new inhibitors of carbonic anhydrase. Bull Exp Biol Med 175:205\u2013209. https:\/\/doi.org\/10.1007\/s10517-023-05835-w","journal-title":"Bull Exp Biol Med"},{"key":"5723_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.138798","volume":"1314","author":"MG Kurban","year":"2024","unstructured":"Kurban MG, \u00c7akmak R, Ba\u015faran E et al (2024) Synthesis of new sulfonamide derivatives: investigation of their interactions with carbonic anhydrase and cholinesterase enzymes by in vitro and in silico evaluations. J Mol Struct 1314:138798. https:\/\/doi.org\/10.1016\/j.molstruc.2024.138798","journal-title":"J Mol Struct"},{"key":"5723_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118912","volume":"194","author":"Q Wang","year":"2026","unstructured":"Wang Q, Qiao H, Yuan W et al (2026) Discovery of novel chalcone derivatives containing benzimidazole possessing anti-tumor potential in vitro and in vivo. Biomed Pharmacother 194:118912. https:\/\/doi.org\/10.1016\/j.biopha.2025.118912","journal-title":"Biomed Pharmacother"},{"key":"5723_CR75","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/1573406412666160307151904","volume":"11","author":"Y Wang","year":"2016","unstructured":"Wang Y, Ma J, Yan X et al (2016) Isoliquiritigenin inhibits proliferation and induces apoptosis via alleviating hypoxia and reducing glycolysis in mouse melanoma B16F10 cells. Recent Pat Anticancer Drug Discov 11:215\u2013227. https:\/\/doi.org\/10.2174\/1573406412666160307151904","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"5723_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.107069","volume":"143","author":"J Ling","year":"2024","unstructured":"Ling J, Li X, Wang M et al (2024) Novel sulfonyl-substituted tetrandrine derivatives for colon cancer treatment by inducing mitochondrial apoptosis and inhibiting PI3K\/AKT\/mTOR pathway. Bioorg Chem 143:107069. https:\/\/doi.org\/10.1016\/j.bioorg.2023.107069","journal-title":"Bioorg Chem"},{"key":"5723_CR77","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-03130-w","volume":"16","author":"JC Espinoza-Hicks","year":"2025","unstructured":"Espinoza-Hicks JC, Salinas-Vera YM, Camarillo-Cisneros J et al (2025) O-prenylchalcones inhibit cell proliferation and activate apoptosis by inducing mitochondrial dysfunction in gastric cancer cells. Discov Oncol 16:1292. https:\/\/doi.org\/10.1007\/s12672-025-03130-w","journal-title":"Discov Oncol"},{"key":"5723_CR78","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1021\/acs.jmedchem.2c02036","volume":"66","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang M, Huang R et al (2023) Novel indole\u2013chalcone derivative-ligated platinum(IV) prodrugs attenuate cisplatin resistance in lung cancer through ROS\/ER stress and mitochondrial dysfunction. J Med Chem 66:4868\u20134887. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c02036","journal-title":"J Med Chem"},{"key":"5723_CR79","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1002\/iub.2689","volume":"74","author":"M Komatsu","year":"2022","unstructured":"Komatsu M (2022) p62 bodies: Phase separation, <scp>NRF2<\/scp> activation, and selective autophagic degradation. IUBMB Life 74:1200\u20131208. https:\/\/doi.org\/10.1002\/iub.2689","journal-title":"IUBMB Life"},{"key":"5723_CR80","doi-asserted-by":"publisher","first-page":"102268","DOI":"10.1016\/j.rechem.2025.102268","volume":"15","author":"J-P Shiau","year":"2025","unstructured":"Shiau J-P, Liu W, Tseng C-H et al (2025) A chalcone\/quinolone hybrid drug (COQM) triggers oxidative stress, DNA damage, and apoptosis to induce selective antiproliferative effects in breast cancer cells. Results Chem 15:102268. https:\/\/doi.org\/10.1016\/j.rechem.2025.102268","journal-title":"Results Chem"},{"issue":"1","key":"5723_CR81","doi-asserted-by":"publisher","first-page":"111456","DOI":"10.1016\/j.yexcr.2019.06.001","volume":"382","author":"MP Thom\u00e9","year":"2019","unstructured":"Thom\u00e9 MP, Pereira LC, Onzi GR et al (2019) Dipyridamole impairs autophagic flux and exerts antiproliferative activity on prostate cancer cells. Exp Cell Res 382:111456. https:\/\/doi.org\/10.1016\/j.yexcr.2019.06.001","journal-title":"Exp Cell Res"},{"key":"5723_CR82","doi-asserted-by":"publisher","DOI":"10.4103\/aja2022105","author":"B Zhao","year":"2023","unstructured":"Zhao B, Wang J, Chen L et al (2023) The role of glutamine metabolism in castration-resistant prostate cancer. Asian J Androl. https:\/\/doi.org\/10.4103\/aja2022105","journal-title":"Asian J Androl"},{"key":"5723_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05008-x","volume":"15","author":"P Lu","year":"2025","unstructured":"Lu P, Xue J, Ji X (2025) Radiosensitizing effects of Withaferin A in gastric cancer cells via autophagy inhibition and mitochondrial disruption. Sci Rep 15:19695. https:\/\/doi.org\/10.1038\/s41598-025-05008-x","journal-title":"Sci Rep"},{"key":"5723_CR84","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe M, Orhon I, Rocchi C et al (2018) Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy 14:1435\u20131455. https:\/\/doi.org\/10.1080\/15548627.2018.1474314","journal-title":"Autophagy"},{"key":"5723_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105582","volume":"168","author":"PMP Ferreira","year":"2021","unstructured":"Ferreira PMP, de Sousa RWR, de Ferreira JR et al (2021) Chloroquine and hydroxychloroquine in antitumor therapies based on autophagy-related mechanisms. Pharmacol Res 168:105582. https:\/\/doi.org\/10.1016\/j.phrs.2021.105582","journal-title":"Pharmacol Res"},{"key":"5723_CR86","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2174\/1568009618666181016164920","volume":"19","author":"S Ning","year":"2019","unstructured":"Ning S, Wang L (2019) The Multifunctional Protein p62 and Its Mechanistic Roles in Cancers. Curr Cancer Drug Targets 19:468\u2013478. https:\/\/doi.org\/10.2174\/1568009618666181016164920","journal-title":"Curr Cancer Drug Targets"},{"key":"5723_CR87","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1128\/MCB.00248-10","volume":"30","author":"A Lau","year":"2010","unstructured":"Lau A, Wang X-J, Zhao F et al (2010) A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between keap1 and p62. Mol Cell Biol 30:3275\u20133285. https:\/\/doi.org\/10.1128\/MCB.00248-10","journal-title":"Mol Cell Biol"},{"key":"5723_CR88","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1080\/15548627.2016.1248018","volume":"13","author":"Y Watanabe","year":"2017","unstructured":"Watanabe Y, Tsujimura A, Taguchi K, Tanaka M (2017) HSF1 stress response pathway regulates autophagy receptor SQSTM1\/p62-associated proteostasis. Autophagy 13:133\u2013148. https:\/\/doi.org\/10.1080\/15548627.2016.1248018","journal-title":"Autophagy"},{"key":"5723_CR89","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.222836","author":"P S\u00e1nchez-Mart\u00edn","year":"2018","unstructured":"S\u00e1nchez-Mart\u00edn P, Komatsu M (2018) p62\/SQSTM1 - steering the cell through health and disease. J Cell Sci. https:\/\/doi.org\/10.1242\/jcs.222836","journal-title":"J Cell Sci"},{"key":"5723_CR90","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1007\/s12013-025-01821-3","volume":"83","author":"AN Joof","year":"2025","unstructured":"Joof AN, Bajinka O, Zhou Y et al (2025) The central role of NRF2 in cancer metabolism and redox signaling: novel insights into crosstalk with ER stress and therapeutic modulation. Cell Biochem Biophys 83:4145\u20134161. https:\/\/doi.org\/10.1007\/s12013-025-01821-3","journal-title":"Cell Biochem Biophys"},{"key":"5723_CR91","doi-asserted-by":"publisher","first-page":"55863","DOI":"10.18632\/oncotarget.10150","volume":"7","author":"AV Shubin","year":"2016","unstructured":"Shubin AV, Demidyuk IV, Komissarov AA et al (2016) Cytoplasmic vacuolization in cell death and survival. Oncotarget 7:55863\u201355889. https:\/\/doi.org\/10.18632\/oncotarget.10150","journal-title":"Oncotarget"},{"key":"5723_CR92","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1002\/cbin.11480","volume":"45","author":"D Nedungadi","year":"2021","unstructured":"Nedungadi D, Binoy A, Pandurangan N et al (2021) Proteasomal dysfunction and ER stress triggers 2\u2019-hydroxy-retrochalcone-induced paraptosis in cancer cells. Cell Biol Int 45:164\u2013176. https:\/\/doi.org\/10.1002\/cbin.11480","journal-title":"Cell Biol Int"},{"key":"5723_CR93","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/cas.70013","volume":"116","author":"X Wen","year":"2025","unstructured":"Wen X, Ma H (2025) Cytoplasmic vacuolization: a fascinating morphological alteration from cellular stress to cell death. Cancer Sci 116:1181\u20131192. https:\/\/doi.org\/10.1111\/cas.70013","journal-title":"Cancer Sci"},{"key":"5723_CR94","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.freeradbiomed.2009.12.016","volume":"48","author":"MJ Yoon","year":"2010","unstructured":"Yoon MJ, Kim EH, Lim JH et al (2010) Superoxide anion and proteasomal dysfunction contribute to curcumin-induced paraptosis of malignant breast cancer cells. Free Radic Biol Med 48:713\u2013726. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2009.12.016","journal-title":"Free Radic Biol Med"},{"key":"5723_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01131-7","volume":"7","author":"G-N Li","year":"2022","unstructured":"Li G-N, Zhao X-J, Wang Z et al (2022) Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation. Signal Transduct Target Ther 7:317. https:\/\/doi.org\/10.1038\/s41392-022-01131-7","journal-title":"Signal Transduct Target Ther"},{"key":"5723_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11070949","volume":"11","author":"A Ghoneum","year":"2019","unstructured":"Ghoneum A, Said N (2019) PI3K-AKT-mTOR and NF\u03baB pathways in ovarian cancer: implications for targeted therapeutics. Cancers (Basel) 11:949. https:\/\/doi.org\/10.3390\/cancers11070949","journal-title":"Cancers (Basel)"},{"key":"5723_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143517","author":"H Li","year":"2021","unstructured":"Li H, Prever L, Hirsch E, Gulluni F (2021) Targeting PI3K\/AKT\/mTOR signaling pathway in breast cancer. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13143517","journal-title":"Cancers (Basel)"},{"key":"5723_CR98","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031353","volume":"23","author":"A Barzegar Behrooz","year":"2022","unstructured":"Barzegar Behrooz A, Talaie Z, Jusheghani F et al (2022) Wnt and PI3K\/Akt\/mTOR survival pathways as therapeutic targets in glioblastoma. Int J Mol Sci 23:1353. https:\/\/doi.org\/10.3390\/ijms23031353","journal-title":"Int J Mol Sci"},{"key":"5723_CR99","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124507","volume":"21","author":"BY Shorning","year":"2020","unstructured":"Shorning BY, Dass MS, Smalley MJ, Pearson HB (2020) The PI3K-AKT-mTOR pathway and prostate cancer: at the crossroads of AR, MAPK, and WNT signaling. Int J Mol Sci 21:4507. https:\/\/doi.org\/10.3390\/ijms21124507","journal-title":"Int J Mol Sci"},{"key":"5723_CR100","doi-asserted-by":"publisher","first-page":"563.e1","DOI":"10.1016\/j.clgc.2021.07.014","volume":"19","author":"J Cham","year":"2021","unstructured":"Cham J, Venkateswaran AR, Bhangoo M (2021) Targeting the PI3K-AKT-mTOR pathway in castration resistant prostate cancer: a review article. Clin Genitourin Cancer 19:563.e1-563.e7. https:\/\/doi.org\/10.1016\/j.clgc.2021.07.014","journal-title":"Clin Genitourin Cancer"},{"key":"5723_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222011088","volume":"22","author":"T Pungsrinont","year":"2021","unstructured":"Pungsrinont T, Kallenbach J, Baniahmad A (2021) Role of PI3K-AKT-mTOR pathway as a pro-survival signaling and resistance-mediating mechanism to therapy of prostate cancer. Int J Mol Sci 22:11088. https:\/\/doi.org\/10.3390\/ijms222011088","journal-title":"Int J Mol Sci"},{"key":"5723_CR102","doi-asserted-by":"crossref","unstructured":"Seyed Karimi M, Faghihkhorasani F, Abdulwahid A-HRR et al (2024)\u00a0Prostate cancer and PTEN\/PI3K\/AKT\/mTOR signaling. In: Prostate cancer: molecular events and therapeutic modalities. Springer Nature Singapore, Singapore, pp 169\u2013182","DOI":"10.1007\/978-981-97-4612-5_8"},{"key":"5723_CR103","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/15384101.2016.1151581","volume":"15","author":"X Qin","year":"2016","unstructured":"Qin X, Jiang B, Zhang Y (2016) 4E-BP1, a multifactor regulated multifunctional protein. Cell Cycle 15:781\u2013786. https:\/\/doi.org\/10.1080\/15384101.2016.1151581","journal-title":"Cell Cycle"},{"key":"5723_CR104","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24332","author":"K Wang","year":"2022","unstructured":"Wang K, Wang K, Ma Q (2022) The expression and significance of p4E-BP1\/4E\u2010BP1 in prostate cancer. J Clin Lab Anal. https:\/\/doi.org\/10.1002\/jcla.24332","journal-title":"J Clin Lab Anal"},{"key":"5723_CR105","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY et al (2023) PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer 22:138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6","journal-title":"Mol Cancer"},{"key":"5723_CR106","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.2147\/DDDT.S268524","volume":"14","author":"S Li","year":"2020","unstructured":"Li S, Zhan Y, Xie Y et al (2020) The impact of icariside II on human prostate cancer cell proliferation, mobility, and autophagy via PI3K-AKT-mTOR signaling pathway. Drug Des Devel Ther 14:4169\u20134178. https:\/\/doi.org\/10.2147\/DDDT.S268524","journal-title":"Drug Des Devel Ther"},{"key":"5723_CR107","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1142\/S0192415X23500477","volume":"51","author":"H-E Wu","year":"2023","unstructured":"Wu H-E, Su C-C, Wang S-C et al (2023) Anticancer effects of morusin in prostate cancer via inhibition of Akt\/mTOR signaling pathway. Am J Chin Med 51:1019\u20131039. https:\/\/doi.org\/10.1142\/S0192415X23500477","journal-title":"Am J Chin Med"},{"key":"5723_CR108","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s11010-024-05026-9","volume":"480","author":"X Gan","year":"2025","unstructured":"Gan X, Luo X, Chen J et al (2025) Ilicicolin C suppresses the progression of prostate cancer by inhibiting PI3K\/AKT\/mTOR pathway. Mol Cell Biochem 480:1089\u20131104. https:\/\/doi.org\/10.1007\/s11010-024-05026-9","journal-title":"Mol Cell Biochem"},{"key":"5723_CR109","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1021\/acs.chemrestox.9b00152","volume":"32","author":"A Zhitkovich","year":"2019","unstructured":"Zhitkovich A (2019) N-acetylcysteine: antioxidant, aldehyde scavenger, and more. Chem Res Toxicol 32:1318\u20131319. https:\/\/doi.org\/10.1021\/acs.chemrestox.9b00152","journal-title":"Chem Res Toxicol"},{"key":"5723_CR110","doi-asserted-by":"publisher","first-page":"102497","DOI":"10.1016\/j.redox.2022.102497","volume":"57","author":"B Kalyanaraman","year":"2022","unstructured":"Kalyanaraman B (2022) NAC, NAC, Knockin\u2019 on Heaven\u2019s door: Interpreting the mechanism of action of N-acetylcysteine in tumor and immune cells. Redox Biol 57:102497. https:\/\/doi.org\/10.1016\/j.redox.2022.102497","journal-title":"Redox Biol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05723-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05723-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05723-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:55:33Z","timestamp":1792569333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05723-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":110,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["5723"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05723-7","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}